In Reply to Tsurugai et al
Int J Radiat Oncol Biol Phys
.
2022 May 1;113(1):229.
doi: 10.1016/j.ijrobp.2022.01.015.
Authors
Nitin Ohri
1
,
Wolfgang A Tomé
1
,
Alejandra Méndez Romero
2
,
Moyed Miften
3
,
Randall K Ten Haken
4
,
Laura A Dawson
5
,
Jimm Grimm
6
,
Ellen Yorke
7
,
Andrew Jackson
7
Affiliations
1
Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York.
2
Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
3
Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado.
4
Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
5
Radiation Medicine Program, Princess Margaret Cancer Centre and Department of Radiation Oncology, University of Toronto, Ontario, Canada.
6
Radiation Oncology and Molecular Radiation Sciences, Geisinger Health System, Wilkes Barre, Pennsylvania.
7
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.
PMID:
35427548
DOI:
10.1016/j.ijrobp.2022.01.015
No abstract available
Publication types
Letter
Comment